98%
921
2 minutes
20
This study evaluates the safety and visual outcomes of enhanced monofocal intraocular lenses compared to standard monofocal intraocular lenses in patients with varying severities of glaucoma. Utilizing data from surgeries performed in 2021, the study involved patients aged 40 and older with visually significant cataracts and diagnosed glaucoma or glaucoma suspects. The findings indicate that both enhanced and standard monofocal lenses lead to significant improvements in best-corrected visual acuity, visual field index, mean deviation, and retinal nerve fiber layer thickness postoperatively. No significant differences were observed between the two groups in the extent of these improvements, suggesting that enhanced monofocal lenses may offer a viable alternative for patients with glaucoma, providing significant visual benefits and potentially better intermediate vision while preserving overall visual function.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11807180 | PMC |
http://dx.doi.org/10.1038/s41598-025-87282-3 | DOI Listing |
BMJ Open Ophthalmol
September 2025
Alcon Research, LLC, Fort Worth, Texas, USA.
Background/aims: Recently, modified monofocal intraocular lenses (IOLs) (proposed mono plus IOLs) have emerged claiming to provide monofocal quality distance vision while enhancing intermediate distance visual performance. The purpose of this study was to conduct a literature review and compare the range of vision following cataract surgery with the implantation of standard monofocal, claimed monofocal plus and extended depth of focus (EDoF) IOLs.
Methods: Literature searches and a meta-analysis were conducted on Embase, PubMed, IOLEvidence App and the Food and Drug Administration premarket approval database.
J Clin Med
August 2025
Eye Clinic, Department of Neuroscience, Psychology, Pharmacology and Child Health (NEUROFARBA), University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
: The Tecnis Eyhance is an enhanced monofocal intraocular lens (IOL) designed to improve intermediate vision without compromising distance clarity or increasing the incidence of photic phenomena. Although short-term results have been encouraging, long-term data remain limited. This study presents the 5-year follow-up of a previously published 6-month clinical evaluation, aiming to assess the stability of visual, optical, and patient-reported outcomes over time.
View Article and Find Full Text PDFIndian J Ophthalmol
September 2025
Department of Ophthalmology, Storm Eye Institute, Medical University of South Carolina, USA.
Purpose: To compare the effect of induced astigmatism and defocus on visual performance in patients with a dominant eye implanted with a dual-technology diffractive intraocular lens (IOL) or an enhanced monofocal IOL.
Methods: This non-randomized cohort study included 35 patients in each group. Group 1 underwent phacoemulsification and received the Tecnis Synergy IOL in the dominant eye.
Clin Ophthalmol
August 2025
Department of Ophthalmology, Tan Tock Seng Hospital, Singapore.
Purpose: To determine the visual performance and patient reported outcomes after bilateral implantation of an enhanced monofocal intraocular lens (IOL) (RayOne EMV RAO200E) targeted for emmetropia or modest monovision.
Patients And Methods: This was a prospective, single-centre, comparative, interventional study. Patients were divided into two groups and targeted for bilateral emmetropia or modest monovision (-1.
Jpn J Ophthalmol
August 2025
Department of Ophthalmology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Purpose: To compare visual function and patient-reported satisfaction among 3 types of monofocal plus intraocular lenses (IOLs) STUDY DESIGN: Retrospective case series METHODS: This study included 122 eyes from 61 patients who underwent bilateral implantation of DIB00V (Johnson & Johnson Vison Care, 22 patients), NSP-3 (Nidek, 18 patients), or XY1-EM (Hoya Surgical Optics, 21 patients) between July 2023 and October 2024. At 3 months postoperatively, corrected distance visual acuity (CDVA) at 5 m, distance-corrected intermediate visual acuity (DCIVA) at 70 cm and 50 cm, manifest refraction, and letter contrast sensitivity were compared. Responses to a questionnaire assessing subjective satisfaction with daily visual activities were analyzed.
View Article and Find Full Text PDF